Lineage Reports Third Quarter 2021 Financial Results and Highlights Progress From Clinical Cell Therapy Programs

Go back to Lineage Reports Third Quarter 2021 Financial Results and Highlights Progress From Clinical Cell Therapy Programs
(NYSE: LCTX) Delayed: 1.25 -0.01 (0.79%)
Previous Close $1.26    52 Week High
Open $1.24    52 Week Low
Day High $1.29    P/E N/A 
Day Low $1.24    EPS
Volume 726,006       

(NYSE: LCTX) Delayed: 1.25 -0.01 (0.79%)
Previous Close $1.26    52 Week High
Open $1.24    52 Week Low
Day High $1.29    P/E N/A 
Day Low $1.24    EPS
Volume 726,006